Agenus | AGEN - Fremdkapital





Fremdkapital Veränderung Datum
AbbVie USD 62.97B 12M 2025-09
Agenus USD 169.66M 146.06M 2025-12
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
CSL USD 10.42B 273M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Glaxosmithkline GBP 19.82B 203.13M 2025-12
Incyte USD 30.2M 5.17M 2025-12
Intrexon USD 0 198.67M 2024-06
J&J USD 39.44B 30M 2025-12
Jiangsu Hengrui CNY 51.42M 5.94M 2025-09
Karyopharm Therapeutics USD -0.93 0.67 2024-12
MacroGenics USD 70M 256K 2025-12
Merck EUR 10.73B 277M 2025-12
Merck USD 39.97B 6B 2025-09
Northwest Biotherapeutics USD 11.04M 4.7M 2023-09
Novartis USD 29.59B 5.35B 2025-12
Novavax USD 246.3M 200K 2025-12
Pfizer USD 57.41B 93M 2025-09
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Rigel Pharmaceuticals USD 0 0 2024-09
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 0 0 2025-03